Ruilan Wang
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
Papers in
- Epidemiology 28
- Sepsis Diagnosis and Treatment 15
- Influenza Virus Research Studies 7
- Pneumonia and Respiratory Infections 4
-
- Respiratory Support and Mechanisms 6
- Co-authors
- Xiaoxiao Meng (25 shared papers)Rui Tian (16 shared papers)Yun Xie (12 shared papers)Hui Xie (5 shared papers)Jiaxiang Zhang (12 shared papers)Yong Zhu (2 shared papers)Luyu Yang (5 shared papers)Yong Zhu (9 shared papers)
- Journals
- BMC Infectious Diseases (6 papers)Journal of Infection (3 papers)Clinical Infectious Diseases (2 papers)The American Journal of Emergency Medicine (2 papers)Journal of Cellular and Molecular Medicine (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ruilan Wang
111 papers receiving 2.2k citations
Ruilan Wang's Hit Papers
Peers
Comparison fields: 5 of 95
- Clinical Biochemistry 67
- Drug Discovery 1
- Infectious Diseases 225
- Pulmonary and Respiratory Medicine 273
- Molecular Medicine 51
Countries citing papers authored by Ruilan Wang
This map shows the geographic impact of Ruilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruilan Wang more than expected).
Fields of papers citing papers by Ruilan Wang
This network shows the impact of papers produced by Ruilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruilan Wang. The network helps show where Ruilan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruilan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 209 | |
| 2 | Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study Hit paper breakdown → | 2023 | 168 |
| 3 | 2017 | 123 | |
| 4 | 2016 | 106 | |
| 5 | 2018 | 104 | |
| 6 | 2019 | 87 | |
| 7 | 2023 | 76 | |
| 8 | 2021 | 71 | |
| 9 | 2021 | 70 | |
| 10 | 2021 | 70 | |
| 11 | 2019 | 59 | |
| 12 | 2017 | 50 | |
| 13 | 2019 | 48 | |
| 14 | 2017 | 42 | |
| 15 | 2024 | 41 | |
| 16 | 2021 | 38 | |
| 17 | 2021 | 38 | |
| 18 | 2018 | 37 | |
| 19 | 2020 | 35 | |
| 20 | Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin. | 2010 | 31 |
About Ruilan Wang
Ruilan Wang is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Surgery, Infectious Diseases and Pharmacology, having authored 116 papers that have together received 2.3k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (15 papers), Paraquat toxicity studies and treatments (11 papers), Influenza Virus Research Studies (7 papers), Respiratory Support and Mechanisms (6 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers), Pneumonia and Respiratory Infections (4 papers), COVID-19 Clinical Research Studies (4 papers) and Acute Kidney Injury Research (3 papers). The work is most often cited by research in Clinical Biochemistry (67 citations), Drug Discovery (1 citation), Infectious Diseases (225 citations), Pulmonary and Respiratory Medicine (273 citations) and Molecular Medicine (51 citations). Ruilan Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xiaoxiao Meng, Rui Tian, Yun Xie, Hui Xie, Jiaxiang Zhang, Yong Zhu, Luyu Yang, Yong Zhu, Shouzhi Fu and Hui Xie. Their work appears in journals such as BMC Infectious Diseases, Journal of Infection, Clinical Infectious Diseases, The American Journal of Emergency Medicine and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.